These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11811359

  • 1. Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril.
    Ma M, Watanabe K, Wahed MI, Inoue M, Sekiguchi T, Kouda T, Ohta Y, Nakazawa M, Yoshida Y, Yamamoto T, Hanawa H, Kodama M, Fuse K, Aizawa Y.
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S51-4. PubMed ID: 11811359
    [Abstract] [Full Text] [Related]

  • 2. Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis.
    Juan W, Nakazawa M, Watanabe K, Ma M, Wahed MI, Hasegawa G, Naito M, Yamamoto T, Fuse K, Kato K, Kodama M, Aizawa Y.
    Mol Cell Biochem; 2003 Sep; 251(1-2):77-82. PubMed ID: 14575307
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of angiotensin II receptor blockade (candesartan) with angiotensin-converting enzyme inhibitor (quinapril) in rats with dilated cardiomyopathy.
    Watanabe K, Juan W, Narasimman G, Ma M, Inoue M, Saito Y, Wahed MI, Nakazawa M, Hasegawa G, Naito M, Tachikawa H, Tanabe N, Kodama M, Aizawa Y, Yamamoto T, Yamaguchi K, Takahashi T.
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S93-7. PubMed ID: 12693379
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension.
    Hocher B, Godes M, Olivier J, Weil J, Eschenhagen T, Slowinski T, Neumayer HH, Bauer C, Paul M, Pinto YM.
    J Hypertens; 2002 Apr; 20(4):745-51. PubMed ID: 11910312
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of quinapril with enalapril in rats with heart failure.
    Watanabe K, Ma M, Wen J, Tachikawa H, Kodama M, Aizawa Y, Yamaguchi K, Takahashi T.
    Pharmacology; 2004 Jul; 71(3):157-61. PubMed ID: 15161998
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.
    Turcani M, Rupp H.
    Br J Pharmacol; 2000 Aug; 130(7):1671-7. PubMed ID: 10928973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR, Jarvis B.
    Drugs; 2002 Aug; 62(2):339-85. PubMed ID: 11817979
    [Abstract] [Full Text] [Related]

  • 20. Improved survival in rats administered NG-nitro L-arginine methyl ester due to converting enzyme inhibition.
    Michel JB, Xu Y, Blot S, Philippe M, Chatellier G.
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):142-8. PubMed ID: 8797148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.